The Precise MRD test is Myriad’s tumor-informed circulating tumor DNA (ctDNA) assay designed to support longitudinal monitoring during cancer treatment. Using whole-genome sequencing to create a ...
SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the fourth quarter and fiscal year ended December 31, 2025.
At 11 years old, Mykela Shields has experienced more hospital stays, tests and procedures than most people will in their lifetime. Her memories consist of the pinch of a blood draw, the ...
Explore Karan Sarin's insightful guide on combating India's metabolic crisis through nutrition, movement, and stress management.
Southwest Florida companies Hertz, Herc, NeoGenomics, and Alico report Q4 and full-year 2025 earnings, showing mixed results.
"Monogenic" diseases, triggered by mutations in just one gene, may actually be more complex than scientists thought.
Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in ...
As new research suggests that core strength and muscle are more important for long-term fitness than aerobic exercise, Harry ...
Opinion
There Is No Over- or Under-diagnosis of ADHD or Autism, Just a Confused Cacophony of Opinions
The public narrative on ADHD, autism, and neurodivergence is infused with scientism—faith-based claims masquerading as scientific ones.
The Companion Diagnostics Market has emerged as a critical pillar of modern precision medicine, enabling healthcare providers to match patients with therapies that are most likely to deliver effective ...
Strategic partnership delivers scalable, CLIA-certified capillary blood testing to support rural Medicaid programs and ...
If the couple being tested is not the baby's biological parents, a group of "less than 20" already-identified couples will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results